查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1803432

核子醫學設備市場（按技術、產品類型、應用和最終用戶分類）—2025-2030 年全球預測

Nuclear Medicine Instrumentation Market by Technology, Product Category, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計核醫設備市場規模在 2024 年將達到 42.3 億美元，在 2025 年將成長至 45.1 億美元，在 2030 年將達到 62.7 億美元，複合年成長率為 6.76%。

主要市場統計數據
基準年2024年 42.3億美元
預計2025年 45.1億美元
預計2030年 62.7億美元
複合年成長率（%） 6.76%

對影響全球醫療保健診斷和治療創新的核子醫學設備進行全面調查

過去十年，核子醫學設備已成為日益個人化診斷和治療途徑的關鍵，徹底改變了臨床醫生檢測和治療複雜疾病的方式。隨著醫療服務提供者努力提高準確性和患者預後，先進的成像模式和靶向放射性藥物輸送系統已成為醫學創新的前沿。這項轉變的推動力源自於檢測器靈敏度、影像重建演算法以及影像和治療能力融合的突破性進展。因此，核子醫學如今在多學科治療模式中佔據著舉足輕重的地位，為在分子層面上洞察生理過程提供了前所未有的視角。

透過人工智慧分析、治療診斷學和精密成像的整合，闡明推動下一代核醫學設備的模式轉移

核子醫學設備格局正在被各種趨勢再形成，這些趨勢正在重新定義臨床工作流程和研究前沿。其中最重要的是將人工智慧和機器學習融入影像擷取和解讀。透過自動化影像分割並以前所未有的精度量化示踪劑攝取，這些演算法正在簡化決策流程並減輕放射科醫生的工作量。同時，分子影像劑兼作治療工具的診療方法的普及，正在為個人化醫療開闢新的維度。標靶放射性核治療現在可以透過診斷反饋迴路進行即時指導，從而確保更高的療效並最大限度地減少脫靶效應。

評估美國關稅對核子醫學設備供應鏈的連鎖反應：製造成本與全球合作

2025年，美國新頒布的關稅政策對核醫設備生態系統產生了多方面的連鎖反應。進口檢測器、CT模組和專用零件的關稅上調，迫使製造商重新評估其全球供應鏈架構。為此，領先的設備製造商正在多元化籌資策略，並加快對本地組裝和零件製造的投資。雖然這些調整旨在抵消不斷上升的進口成本，但鑑於放射性物質和診斷成像設備所適用的嚴格安全標準，它們也帶來了品管和法規合規的複雜性。

從核醫設備市場綜合技術產品類型應用和最終用戶細分中獲得的策略見解

從技術採用、產品類型差異化、臨床應用和最終用戶專業化角度獲得的洞察揭示了塑造當今核醫學市場的複雜因素。包括 PET/CT 和 SPECT/CT 在內的混合影像平台的演變，凸顯了向無縫整合功能和解剖數據並滿足腫瘤分期和神經系統評估嚴格要求的系統轉變。同時，診斷和治療設備與放射性藥物之間的界限凸顯了雙軌策略：一方面側重於影像採集和解讀，另一方面側重於靶向放射性配體的治療遞送。

了解美洲、歐洲、中東、非洲和亞太地區的區域動態，以揭示核子醫學影像的成長動力和採用模式

美洲、中東和非洲以及亞太地區的區域動態正在推動不同的採用率和創新軌跡。在美洲，完善的醫療保健基礎設施和雄厚的研究資金持續推動先進 PET/CT 和診療平台的早期應用。北美醫療機構正在大規模採用整合成像模式，而拉丁美洲市場對可攜式SPECT/CT 解決方案的興趣日益濃厚，旨在將診斷服務擴展到都市區。

了解全球核子醫學設備主要參與企業的競爭領導力和協作創新策略

核子醫學設備領域的主要參與企業正在採取多管齊下的策略，以保持競爭優勢並促進技術應用。大型跨國公司透過有針對性的收購和策略研究合作，不斷擴展產品系列，將先進的檢測器技術和人工智慧軟體融入其現有平台。同時，區域性中型公司則專注於經濟高效的模組化系統和迎合新興市場的在地服務模式，開拓專業化的利基市場。

產業領導者制定可行的藍圖，以最佳化技術投資、建立策略夥伴關係並改善患者治療效果

為了抓住技術融合和監管變革帶來的機會，產業領導者應優先對用於診斷成像和治療應用的模組化、可擴展平台進行策略性投資。採用靈活的製造框架有助於加速下一代檢測器和放射性藥物的部署，同時減少供應鏈中斷。建立由監管事務、臨床專家和資料科學家組成的跨職能團隊，可以進一步簡化產品核可流程，並提高市場應對力。

嚴格的混合方法的詳細資訊，該方法將一手資料和二手資料研究與先進的分析技術相結合，以確保數據的完整性和可靠性

研究採用混合方法框架，將與臨床醫生、影像專業人員和採購主管進行的廣泛一手資料研究與嚴謹的二手資料研究相結合，包括同行評審期刊、監管資料庫和專利申請。一手資料提供了對臨床工作流程、採購標準和新興需求的定性洞察，而二手資料則提供了背景檢驗和趨勢分析。這些輸入經過三角檢驗，以協調不同的觀點，隨後進行交叉檢驗研討會，以完善關鍵假設並確保研究的穩健性。

將關鍵發現綜合成前瞻性的觀點，引導相關人員了解核醫新興趨勢的機會與策略重要性

這份全面的評估揭示了決定核醫設備未來發展的關鍵技術創新、監管因素和競爭動態。從混合影像系統和人工智慧主導的分析技術，到診療範式的興起，相關人員將有機會釋放巨大的臨床和營運價值。關稅驅動的供應鏈調整和區域差異化進一步凸顯了敏捷策略規劃和穩健夥伴關係生態系統的必要性。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 融合人工智慧和機器學習，提升PET掃描器影像重建的準確性和速度
  • 開發無迴旋加速器放射性同位素生產，以分散社區醫療機構對 PET 示踪劑的獲取
  • 固體檢測器的進步將提高下一代 SPECT 系統的飛行時間解析度
  • 腫瘤靶向放射性核素治療與診斷影像結合的診療設備的出現
  • 實施數位雙胞胎模擬以最佳化核子醫學設備的工作流程和維護計劃
  • 整合雲端基礎的資料管理，用於多模態核成像研究，實現即時遠端解釋
  • 小巧、可攜式的伽馬攝影機有助於緊急心肌灌注成像
  • 引入具有超高場強磁體的混合 PET/MRI 系統可改善腦部影像中的軟組織對比度

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第8章核子醫學設備市場：依技術

  • 混合成像
    • PET/CT系統
    • SPECT/CT系統
  • 正子斷層掃描
  • 單光子發射電腦斷層掃描

第9章核醫設備市場（依產品類型）

  • 診斷設備
  • 治療設備和放射性藥物

第 10 章核醫設備市場：按應用

  • 心臟病學
  • 神經病學
  • 腫瘤學

第 11 章 核醫設備市場（依最終使用者）

  • 診斷影像中心
  • 醫院
  • 研究所

第 12 章：美洲核子醫學設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 13 章：歐洲、中東和非洲的核子醫學設備市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

第14章：亞太核醫學設備市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • AMETEK Inc.
    • BJ Madan & Co
    • Berthold Technologies GmbH & Co.KG
    • Blue Earth Diagnostics
    • Bruker Corporation
    • Canon Medical Systems Corporation
    • Cardinal Health
    • COMECER SpA
    • Digirad
    • Exosens
    • GE Healthcare
    • Geebee International
    • Hidex Oy
    • Jubilant DraxImage, Inc.
    • Koninklijke Philips NV
    • Mirion Technologies, Inc.
    • Neusoft Medical Systems Co., Ltd.
    • Nucleonix Systems（P）Ltd.
    • Nucleuz Healthcare Pvt Ltd
    • NUVIATech Healthcare
    • OVIS Imaging Solutions
    • Radiation Monitoring Devices
    • Rotem Industries Ltd.
    • Siemens Healthineers AG
    • Spectrum Instrumentation

第16章 研究人工智慧

第17章 研究統計

第18章 研究聯絡人

第19章 研究報導

第20章 附錄

Product Code: MRR-546E6FBB3C4B

The Nuclear Medicine Instrumentation Market was valued at USD 4.23 billion in 2024 and is projected to grow to USD 4.51 billion in 2025, with a CAGR of 6.76%, reaching USD 6.27 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.23 billion
Estimated Year [2025] USD 4.51 billion
Forecast Year [2030] USD 6.27 billion
CAGR (%) 6.76%

A Comprehensive Exploration of Nuclear Medicine Instrumentation Shaping Diagnostic and Therapeutic Innovations in Healthcare Delivery Worldwide

Over the past decade, nuclear medicine instrumentation has increasingly become a linchpin in personalized diagnostic and therapeutic pathways, revolutionizing how clinicians detect and treat complex diseases. As healthcare providers strive to enhance precision and patient outcomes, advanced imaging modalities and targeted radiopharmaceutical delivery systems have emerged at the forefront of medical innovation. This transformation has been driven by breakthroughs in detector sensitivity, image reconstruction algorithms, and the convergence of imaging with therapeutic functions. Consequently, nuclear medicine now occupies a pivotal position within multidisciplinary care paradigms, offering unparalleled insights into physiological processes at the molecular level.

Transitioning from conventional gamma cameras to sophisticated hybrid platforms, the field has undergone a profound metamorphosis. Hybrid imaging systems that combine positron emission tomography with computed tomography or single photon emission computed tomography with CT have enabled seamless integration of anatomical and functional data. These developments have not only sharpened diagnostic confidence but also expanded the scope of applications across cardiology, neurology, and oncology. Moreover, the ongoing miniaturization of components, along with enhancements in data processing and radiopharmaceutical chemistry, continues to lower operational barriers, facilitating broader adoption across hospitals, diagnostic centers, and research institutions. This report embarks on a comprehensive exploration of these technological advances, regulatory evolutions, and market dynamics, laying a solid foundation for the in-depth analysis that follows.

Unveiling the Paradigm Shifts Driving Next Generation Nuclear Medicine Instrumentation Through Integration of AI Analytics Theranostics and Precision Imaging

The landscape of nuclear medicine instrumentation has been reshaped by converging trends that are redefining clinical workflows and research frontiers. Foremost among these is the integration of artificial intelligence and machine learning into image acquisition and interpretation. By automating image segmentation and quantifying tracer uptake with unprecedented precision, these algorithms are streamlining decision-making and alleviating radiologist workloads. Simultaneously, the surge in theranostic approaches-where molecular imaging agents double as therapeutic vehicles-has introduced a new dimension of personalized medicine. Targeted radionuclide therapies are now guided in real time by diagnostic feedback loops, ensuring higher efficacy and minimizing off-target effects.

Additionally, the emphasis on hybrid imaging systems has fostered cross-disciplinary collaborations, uniting experts in radiopharmaceutical chemistry, nuclear physics, and bioengineering. This collective effort has given rise to next-generation detectors utilizing novel scintillating materials and semiconductor technology, thereby elevating spatial resolution and sensitivity. The growing need for point-of-care diagnostics has also spurred the development of compact, portable SPECT/CT and PET/CT systems, facilitating decentralized clinical trials and improving access in remote or community-based settings. Collectively, these transformative shifts underscore a trajectory toward faster, smarter, and more patient-centric nuclear medicine practices.

Assessing the Ripple Effects of United States Tariffs on Nuclear Medicine Instrumentation Supply Chains Manufacturing Costs and Global Collaboration

In 2025, newly enacted United States tariff policies have generated multifaceted ripple effects across the nuclear medicine instrumentation ecosystem. Heightened duties on imported detectors, CT modules, and specialized components have compelled manufacturers to reassess global supply chain architectures. In response, leading original equipment manufacturers are diversifying their sourcing strategies and accelerating investments in local assembly and component fabrication. While these adjustments aim to offset increased import costs, they also introduce complexities in quality control and regulatory compliance, given the stringent safety standards governing radioactive materials and imaging devices.

Consequently, distributors and end users are recalibrating procurement plans to accommodate extended lead times and restructured pricing models. Some institutions have turned to consortia agreements to leverage collective purchasing power and negotiate more favorable terms with suppliers. At the same time, research partners are exploring alternative detector chemistries and modular designs that can be adapted to regional manufacturing capabilities. Through these adaptive measures, stakeholders are striving to maintain uninterrupted clinical operations and uphold high standards of patient care. This section examines how the tariff environment is catalyzing innovation in production processes, spurring supply chain resilience, and redefining international collaboration within the nuclear medicine sector.

Strategic Insights Emerging from Comprehensive Technology Product Category Application and End User Segmentation in Nuclear Medicine Instrumentation Markets

Insights drawn from technology adoption, product category differentiation, clinical application, and end-user specialization reveal the intricate drivers shaping today's nuclear medicine market. The evolution of hybrid imaging platforms, including PET/CT and SPECT/CT modalities, underscores a shift toward systems that seamlessly integrate functional and anatomical data, satisfying the exacting requirements of oncological staging and neurological assessment. Simultaneously, the delineation between diagnostic instruments and therapeutic instruments coupled with radiopharmaceuticals highlights a dual-track strategy: one focused on image acquisition and interpretation, the other on delivering targeted radioligands for treatment.

Clinical fields such as cardiology, neurology, and oncology are each benefitting uniquely from these advancements, with oncology driving the largest volume of tracer development and neurology increasingly leveraging imaging biomarkers for neurodegenerative conditions. Moreover, the dispersal of capabilities across diagnostic imaging centers, hospitals, and research institutions reflects a broadening user base that demands scalable solutions. Diagnostic imaging centers prioritize throughput and cost efficiency, while hospitals emphasize integrated workflows within electronic health record systems. Meanwhile, research institutes underpin innovation pipelines, validating novel radiotracers and pilot-testing miniaturized instrumentation. These layered insights inform strategic positioning and product development roadmaps for stakeholders operating across the full spectrum of nuclear medicine instrumentation.

Understanding Regional Dynamics in the Americas Europe Middle East Africa and Asia Pacific to Uncover Growth Drivers and Adoption Patterns in Nuclear Imaging

Regional dynamics are driving divergent adoption rates and innovation trajectories across the Americas, Europe Middle East Africa region, and the Asia Pacific. In the Americas, established healthcare infrastructures and substantial research funding continue to foster early adoption of advanced PET/CT and theranostic platforms. North American centers are increasingly deploying integrated imaging therapies at scale, while Latin American markets demonstrate growing interest in portable SPECT/CT solutions to expand diagnostic access beyond urban hubs.

Across Europe, Middle East, and Africa, regulatory harmonization efforts and pan-regional research collaborations are enabling cross-border clinical trials and enhanced data sharing. Western European nations maintain leadership in radiopharmaceutical development, whereas emerging markets in the Gulf cooperation council countries and Southern Africa are investing in modernizing nuclear infrastructure. Meanwhile, the Asia Pacific region is characterized by rapid expansion driven by rising noncommunicable disease prevalence and robust government initiatives. Countries such as China, Japan, and India are scaling up local manufacturing capabilities and forging strategic alliances with global technology providers. These regional contrasts provide invaluable guidance for tailoring market entry approaches and aligning stakeholder investments with localized healthcare priorities.

Revealing Competitive Leadership and Collaborative Innovation Strategies Adopted by Key Global Participants in Nuclear Medicine Instrumentation

Leading participants in the nuclear medicine instrumentation sector are adopting multifaceted strategies to maintain competitive advantage and stimulate technology diffusion. Major global corporations continue to expand their product portfolios through targeted acquisitions and strategic research partnerships, embedding advanced detector technologies and AI-powered software into existing platforms. Concurrently, mid-sized regional players are carving out specialized niches by focusing on cost-effective modular systems and localized service models that cater to emerging markets.

Innovation alliances between imaging equipment manufacturers and radiopharmaceutical developers are accelerating integrated theranostic solutions, enabling coordinated roll-outs of diagnostic agents and companion therapies. Furthermore, joint ventures with academic institutions are enhancing R&D pipelines, particularly in developing novel tracers for neuroinflammation and receptor-targeted oncology. By balancing broad geographic reach with deep domain expertise, these organizations are cultivating resilient supply chains, reinforcing after-sales support networks, and driving sustained customer loyalty. The synthesis of these competitive and collaborative initiatives shapes a dynamic landscape where continuous innovation and partnership agility are paramount.

Formulating Practical Roadmaps for Industry Leaders to Optimize Technology Investments Forge Strategic Partnerships and Enhance Patient Outcomes

To harness the opportunities presented by technological convergence and regulatory evolution, industry leaders should prioritize strategic investments in modular, scalable platforms that accommodate both diagnostic imaging and therapeutic applications. By adopting flexible manufacturing frameworks, organizations can mitigate supply chain disruptions while accelerating deployment of next-generation detectors and radiopharmaceuticals. Establishing cross-functional teams that include regulatory affairs, clinical specialists, and data scientists can further streamline product approval timelines and enhance market responsiveness.

Collaboration with academic research centers and contract development organizations will be essential for fast-tracking the discovery and validation of novel tracers. Equally important is the cultivation of a comprehensive digital ecosystem, integrating advanced analytics and cloud-based image management to support remote interpretations and decentralized clinical trials. Building robust training programs for technologists and clinicians will drive effective technology utilization and foster stakeholder confidence. Ultimately, aligning these initiatives with patient-centered value propositions and health economic models will ensure that investments translate into measurable clinical benefits and sustainable growth trajectories.

Detailing Rigorous Mixed Methodology Combining Primary Engagement Secondary Research and Advanced Analytical Techniques to Ensure Data Integrity and Reliability

This research employs a mixed-methodology framework, combining extensive primary engagements with clinicians, imaging specialists, and procurement executives with rigorous secondary research across peer-reviewed journals, regulatory databases, and patent filings. Primary interviews and surveys yield firsthand qualitative insights into clinical workflows, purchasing criteria, and emerging needs, while secondary data sources provide contextual validation and trend analysis. Triangulation of these inputs ensures robustness, with cross-verification workshops conducted to reconcile divergent perspectives and refine key assumptions.

Quantitative analysis includes benchmarking component lifecycles, pricing variances, and throughput metrics, supported by statistical modeling to identify correlation patterns and technology adoption curves. A systematic review of regulatory pathways and reimbursement policies informs the risk assessment of market entry scenarios. Finally, iterative expert validation sessions with academic and industry advisory panels serve to stress-test the findings and calibrate strategic recommendations. This methodological rigor guarantees that the conclusions drawn are both actionable and reflective of real-world dynamics in the nuclear medicine instrumentation landscape.

Synthesizing Key Findings into Forward Looking Perspective Guiding Stakeholders on Emerging Trends Opportunities and Strategic Imperatives in Nuclear Medicine

This comprehensive assessment has illuminated the critical technological innovations, regulatory factors, and competitive dynamics that are defining the future of nuclear medicine instrumentation. From the ascendancy of hybrid imaging systems and AI-driven analytics to the emergence of theranostic paradigms, stakeholders are positioned to unlock significant clinical and operational value. Tariff-induced supply chain adaptations and regional differentiation further underscore the necessity for agile strategic planning and robust partnership ecosystems.

Looking ahead, the convergence of digital health platforms, precision radiopharmaceuticals, and decentralized diagnostic capabilities will continue to drive differentiation. Organizations that integrate cross-disciplinary expertise, prioritize patient-centric workflows, and commit to ongoing innovation will lead the next wave of growth. By synthesizing the insights presented herein, decision makers can confidently navigate emerging challenges, seize value creation opportunities, and advance the standard of care in nuclear medicine.

In summary, the trajectory of nuclear medicine instrumentation is characterized by rapid evolution and multifaceted opportunity. The strategic imperatives outlined in this report offer a clear roadmap for stakeholders seeking to translate cutting-edge science into tangible healthcare impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of artificial intelligence and machine learning for enhanced PET scanner image reconstruction accuracy and speed
  • 5.2. Development of cyclotron-free radioisotope production to decentralize access to PET tracers in regional healthcare facilities
  • 5.3. Advancements in solid-state photodetectors improving time-of-flight resolution in next-generation SPECT systems
  • 5.4. Emergence of theranostic instrumentation combining targeted radionuclide therapy and diagnostic imaging in oncology
  • 5.5. Implementation of digital twin simulations to optimize workflow and maintenance schedules for nuclear medicine equipment
  • 5.6. Integration of cloud-based data management for multimodal nuclear imaging studies enabling real-time remote interpretation
  • 5.7. Miniaturized portable gamma cameras facilitating point-of-care myocardial perfusion imaging in emergency settings
  • 5.8. Adoption of hybrid PET/MRI systems with ultra-high field strength magnets for improved soft tissue contrast in brain imaging

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Nuclear Medicine Instrumentation Market, by Technology

  • 8.1. Introduction
  • 8.2. Hybrid Imaging
    • 8.2.1. PET/CT Systems
    • 8.2.2. SPECT/CT Systems
  • 8.3. Positron Emission Tomography
  • 8.4. Single Photon Emission Computed Tomography

9. Nuclear Medicine Instrumentation Market, by Product Category

  • 9.1. Introduction
  • 9.2. Diagnostic Instruments
  • 9.3. Therapeutic Instruments & Radiopharmaceuticals

10. Nuclear Medicine Instrumentation Market, by Application

  • 10.1. Introduction
  • 10.2. Cardiology
  • 10.3. Neurology
  • 10.4. Oncology

11. Nuclear Medicine Instrumentation Market, by End User

  • 11.1. Introduction
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Americas Nuclear Medicine Instrumentation Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Nuclear Medicine Instrumentation Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Nuclear Medicine Instrumentation Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. AMETEK Inc.
    • 15.3.2. B J Madan & Co
    • 15.3.3. Berthold Technologies GmbH & Co.KG
    • 15.3.4. Blue Earth Diagnostics
    • 15.3.5. Bruker Corporation
    • 15.3.6. Canon Medical Systems Corporation
    • 15.3.7. Cardinal Health
    • 15.3.8. COMECER SpA
    • 15.3.9. Digirad
    • 15.3.10. Exosens
    • 15.3.11. GE Healthcare
    • 15.3.12. Geebee International
    • 15.3.13. Hidex Oy
    • 15.3.14. Jubilant DraxImage, Inc.
    • 15.3.15. Koninklijke Philips N.V.
    • 15.3.16. Mirion Technologies, Inc.
    • 15.3.17. Neusoft Medical Systems Co., Ltd.
    • 15.3.18. Nucleonix Systems (P) Ltd.
    • 15.3.19. Nucleuz Healthcare Pvt Ltd
    • 15.3.20. NUVIATech Healthcare
    • 15.3.21. OVIS Imaging Solutions
    • 15.3.22. Radiation Monitoring Devices
    • 15.3.23. Rotem Industries Ltd.
    • 15.3.24. Siemens Healthineers AG
    • 15.3.25. Spectrum Instrumentation

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. NUCLEAR MEDICINE INSTRUMENTATION MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. NUCLEAR MEDICINE INSTRUMENTATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. NUCLEAR MEDICINE INSTRUMENTATION MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. NUCLEAR MEDICINE INSTRUMENTATION MARKET: RESEARCHAI
  • FIGURE 24. NUCLEAR MEDICINE INSTRUMENTATION MARKET: RESEARCHSTATISTICS
  • FIGURE 25. NUCLEAR MEDICINE INSTRUMENTATION MARKET: RESEARCHCONTACTS
  • FIGURE 26. NUCLEAR MEDICINE INSTRUMENTATION MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. NUCLEAR MEDICINE INSTRUMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PET/CT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PET/CT SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SPECT/CT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SPECT/CT SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY THERAPEUTIC INSTRUMENTS & RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY THERAPEUTIC INSTRUMENTS & RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 46. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 47. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 48. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 49. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 50. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 51. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 52. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 53. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 54. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 55. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. AMERICAS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 57. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 58. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 59. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 60. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 61. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 62. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 63. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 64. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 65. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 66. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 67. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 68. UNITED STATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 69. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 70. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 71. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 72. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 73. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 74. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 75. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 76. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 77. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. CANADA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 79. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 80. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 81. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 82. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 83. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 84. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 85. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 86. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 87. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 88. MEXICO NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 89. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 90. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 91. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 92. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 93. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 94. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 95. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 96. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 97. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. BRAZIL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 99. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 100. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 101. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 102. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 103. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 104. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 105. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 107. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. ARGENTINA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED KINGDOM NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 131. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 132. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 133. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 134. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 135. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 136. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 137. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 139. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. GERMANY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 141. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 143. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 144. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 145. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 146. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 147. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 149. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. FRANCE NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 151. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 153. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 154. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 155. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 156. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 157. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 159. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. RUSSIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 161. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 163. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 164. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 165. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 166. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 167. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 169. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. ITALY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 171. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 172. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 173. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 174. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 175. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 176. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 177. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 179. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. SPAIN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 191. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 194. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 196. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. SAUDI ARABIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 202. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 204. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 206. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. SOUTH AFRICA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 211. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 213. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 214. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 215. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 216. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 217. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 219. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. DENMARK NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 221. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 223. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 224. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 226. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. NETHERLANDS NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 231. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 233. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 234. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 235. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 236. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 237. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 239. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. QATAR NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 241. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 243. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 244. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 245. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 246. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 247. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 249. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. FINLAND NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 251. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 253. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 254. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 255. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 256. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 257. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 259. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. SWEDEN NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 261. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 263. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 264. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 265. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 266. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 267. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 269. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. NIGERIA NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 271. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 273. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 274. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 275. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 276. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 277. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 279. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EGYPT NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 281. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 283. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 284. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 285. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 286. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 287. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 289. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. TURKEY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 291. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 293. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (USD MILLION)
  • TABLE 294. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2025-2030 (USD MILLION)
  • TABLE 295. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 296. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY PRODUCT CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 297. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 299. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. ISRAEL NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 301. NORWAY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 302. NORWAY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 303. NORWAY NUCLEAR MEDICINE INSTRUMENTATION MARKET SIZE, BY HYBRID IMAGING, 2018-2024 (U